[1] Jessen S, Gu B, Dai X. Pygopus and the Wnt signaling pathway: a diverse set of connections[J]. Bioessays, 2008, 30(5):448456.
[2] Li B, Mackay D R, Ma J, et al. Cloning and developmental expression of mouse pygopus 2, a putative Wnt signaling component [J]. Genomics, 2004, 84(2): 398405.
[3] Schwab KR, Patterson LT, Hartman HA, et al. Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development[J]. BMC Biol, 2007, 5:15.
[4] Chen J, Luo Q, Yuan Y, et al. Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stemlike cell expansion[J]. Mol Cell Biol, 2010, 30(24):56215635.
[5] Cantu C, Valenta T, Hausmann G, et al. The Pygo2H3K4me2/3 interaction is dispensable for mouse development and Wnt signalingdependent transcription[J]. Development, 2013, 140(11): 23772386.
[6] Gu B, Watanabe K, Sun P, et al. Chromatin effector pygo2 mediates wntnotch crosstalk to suppress luminal/alveolar potential of mammary stem and Basal cells[J]. Cell Stem Cell, 2013, 13(1):4861.
[7] Chen YY, Li BA, Wang HD, et al. The role of Pygopus 2 in rat glioma cell growth[J]. Med Oncol, 2011, 28(2):631640.
[8] Wang ZX, Chen YY, Li BA, et al. Decreased pygopus 2 expression suppresses glioblastoma U251 cell growth[J]. J Neurooncol, 2010, 100(1):3141.
[9] Zhou SY, Xu ML, Wang SQ, et al. Overexpression of Pygopus2 is required for canonical Wnt activation in human lung cancer[J]. Oncol Lett, 2014, 7(1):233238.
[10] Andrews PG, He Z, Popadiuk C, et al. The transcriptional activity of Pygopus is enhanced by is interaction with cAMPresponseelementbinding protein (CREB)binding protein[J]. Biochem J, 2009, 422(3):493501.
[11] Gu B, Sun P, Yuan Y, et al. Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation [J]. J Cell Biol, 2009, 185(5):811826.
[12] Narytnyk A, Gillinder K, Verdon B, et al. Neural crest stem cellspecific deletion of the Pygopus2 gene modulates hair follicle development[J]. Stem Cell Rev, 2014, 10(1):6068.
[13] Miller TC, Rutherford TJ, Johnson CM, et al. Allosteric remodelling of the histone H3 binding pocket in the Pygo2 PHD finger triggered by its binding to the B9L/BCL9 cofactor[J]. J Mol Biol, 2010, 401(5):969984.
[14] Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy[J]. Cell, 2012, 150(1):1227.
[15] Gu B, Watanabe K, Dai X. Pygo2 regulates histone gene expression and H3 K56 acetylation in human mammary epithelial cells[J]. Cell Cycle, 2012, 11(1):7987.
[16] Kessler R, Hausmann G, Basler K, et al. The PHD domain is required to link Drosophila Pygopus to Legless/betacatenin and not to histone H3[J]. Mech Dev, 2009, 126(89):752759.
[17] Watanabe K, Fallahi M, Dai X. Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTVWnt1 mice[J]. Oncogene, 2014, 33(5):632642.
[18] Cruceru ML, Neagu M, Demoulin JB, et al. Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms[J]. J Cell Mol Med, 2013, 17(10):12181235.
[19] Thorne CA, Hanson AJ, Schneider J, et al. Smallmolecule inhibition of Wnt signaling through activation of casein kinase 1alpha [J]. Nat Chem Biol, 2010, 6(11):829836.
[20] Zhang N, Wei P, Gong A, et al. FoxM1 promotes betacatenin nuclear localization and controls Wnt targetgene expression and glioma tumorigenesis[J]. Cancer Cell, 2011, 20(4): 427442. |